Partners in London and continental Europe from Linklaters, Kirkland & Ellis, Garrigues and Chiomenti have been named on a ...

Health sector stocks fluctuate amid DOJ probe into UnitedHealth (UNH), Gilead upgrade for HIV treatments, and Moderna's focus on non-COVID approvals.

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

Sanofi and CD&R sign Opella share purchase agreementParis, February 19, 2025. Following completion of the required social and corporate ...

About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across the world, is dedicated to ...

We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other foreign ...

OpenAI’s big rebranding effort brings a new logo and a new typeface ... When asked whether OpenAI used the company’s AI-powered tools like ChatGPT to create the designs, Moeller told Wallpaper ...

L’Oreal will sell part of its stake in Sanofi back to the French pharmaceutical company for 3 billion euros ($3.11 billion), bolstering its balance sheet while the beauty industry is undergoing ...

L’Oreal OR-1.27%decrease; red down pointing triangle will sell part of its stake in Sanofi SAN-0.21%decrease; red down pointing triangle back to the French pharmaceutical company for 3 billion ...

In October 2024, Sanofi entered talks with US private equity company Clayton Dubilier & Rice (CD&R) over the sale of Opella, valued at around $17bn. A deal is slated to be completed by Q2 this year.

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company takes its lead candidate through a prostate cancer trial. The Pb-212 ...